BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) shares passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.72 and traded as low as $0.5650. BIO-key International shares last traded at $0.5750, with a volume of 139,417 shares traded.
Analysts Set New Price Targets
BKYI has been the subject of a number of analyst reports. Wall Street Zen upgraded BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.
Get Our Latest Research Report on BKYI
BIO-key International Price Performance
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its earnings results on Friday, November 14th. The technology company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.03). The business had revenue of $1.55 million during the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative return on equity of 73.33% and a negative net margin of 70.23%.
About BIO-key International
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Featured Stories
- Five stocks we like better than BIO-key International
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A month before the crash
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
